
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Nephrogenic diabetes insipidus secondary prevention
Introduction
Overview
Overview
AVPR2is the only gene known to be associated with X-linked nephrogenetic diabetes insipidus. AQP2is the only gene known to be associated with autosomal recessive and autosomal dominant nephrogenetic diabetes insipidus.
Secondary Prevention
Secondary Prevention
Surveillance
- Monitoring of growth in infants and children
- Periodic measurement of serum sodium concentration to identify unrecognized hyperosmolality and early dehydration. Note: Urine output and urine specific gravity are useless as indicators of hydration status.
- Annual renal ultrasound evaluation to monitor for hydronephrosis and megacystis [Shalev et al 2004]
Testing of Relatives at Risk
It is appropriate to evaluate at-risk infants as early as possible to allow for prompt diagnosis and treatment to reduce morbidity from hypernatremia, dehydration, and dilation of the urinary tract
Molecular Genetic Testing
Clinical Uses
- Diagnostic testing
- Carrier testing
- Prenatal diagnosis
Clinical Testing
- Sequence analysis
- Sequence analysis of the AVPR2 gene detects almost 95% of disease-causing mutations in individuals with X-linked NDI.
- Sequence analysis of the AQP2 gene detects almost 95% of disease-causing mutations in individuals with autosomal recessive or autosomal dominant NDI.
- Linkage analysis. Linkage analysis may be performed:
- To confirm cosegregation of a potential pathogenic mutation with disease in individual families and
- As an ancillary test to obtain preliminary data prior to the completion of sequence analysis. Linkage testing cannot be used to confirm the diagnosis of NDI [Arthus et al 2000].
References
References
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
